A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1998
10/13/1998	US5821231 Treatment of immunoinflammatory conditions
10/13/1998	US5821230 GnRH antagonist decapeptides
10/13/1998	US5821227 Modulators of cytokines of the tgf β superfamily
10/13/1998	US5821226 Using bile salt-activated lipase fragments to deliver drugs to the intestines
10/13/1998	US5821225 Substituted at position 22-31 of amino acid sequence of a peptide of parathyroid hormone or parathyroid hormone related peptide
10/13/1998	US5821224 Purified beta-defensin with consensus sequence having net positive charge that lacks three consecutive basic amino acids at the carboxyl terminus; polyclonal and monoclonal antibodies and drugs
10/13/1998	US5821223 Plasminogen-like growth factor
10/13/1998	US5821221 Drug delivery; sustained release
10/13/1998	US5821220 Method of producing concentrated non-buffered solutions of fibronectin
10/13/1998	US5821219 Opioid antagonists and methods of their use
10/13/1998	US5821218 Regeneration of kidney tissue and use of autocrine growth factors
10/13/1998	US5821217 Carbohydrates, water, vitamins, minerals, free amino acids and a potassium or sodium salt
10/13/1998	US5821124 Hybridoma cell lines and antibodies that bind noggin
10/13/1998	US5821123 Modified antibody variable domains
10/13/1998	US5821122 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
10/13/1998	US5821121 Gently rupturing basement lamina of human pancreatic whole islet, culturing in medium capable of supporting cell growth while new cell develops through rupture, culturing new cell or progeny which secrete insulin for at least three months
10/13/1998	US5821117 Porcine cell comprising alpa-1,3 galactosyl transferase
10/13/1998	US5821106 Salmonase prepared from a korean viper
10/13/1998	US5821105 Tissue plasminogen activator having zymognic or fibrin specific properties
10/13/1998	US5821103 Deoxyribonuclease
10/13/1998	US5821091 Method of identifying activated T-cells
10/13/1998	US5821088 Use of gram-positive bacteria to express recombinant proteins
10/13/1998	US5821086 Polynucleotide fragment encoding polypeptide
10/13/1998	US5821085 Culturing; isolation; antigenic
10/13/1998	US5821081 Nucleic acids encoding antiviral proteins and peptides, vectors and host cells comprising same, and methods of producing the antiviral proteins and peptides
10/13/1998	US5821080 A namalwa cell line which is free of squirrel monkey retrovirus; useful for alpha-interferon production
10/13/1998	US5821079 Vectors for the expression and secretion of hirudin by transformed yeasts
10/13/1998	US5821078 Nucleic acid encoding interferon-α/β binding protein
10/13/1998	US5821071 By introducing a nucleotide sequence encoding a syk gene; gene expression; phosphorylation of fc-gamma receptors; for combatting infections
10/13/1998	US5821070 Antibodies reactive with retinoblastoma binding proteins and methods of using same
10/13/1998	US5821056 Polynucleotide; expression vector; binding of antibody to a growth differentiation factor-9 polypeptide indicates the presence of an oocyte
10/13/1998	US5821053 LIL-Stat DNA binding sites and methods for identifying inhibitory binding agents
10/13/1998	US5821051 Combining e6 protein, e6 binding protein, and test compound,detecting formation of complex; identifying agents which affect protein binding; human papillomavirus
10/13/1998	US5820883 Administering two separately microencapsulated active agents; first agent causes primary immune response, second agent is released in pulsating manner to potentiate response
10/13/1998	US5820872 Methods and compositions for improving the effectiveness of X-irradiation therapy for the treatment of an internal solid tumor
10/13/1998	US5820863 A non-naturally occuring non-rodent zona pellucida polypeptide which is the expression product of dna encoding a mammalian zona pellucia polypeptide having immunological cross-reactivity with zona pellucida protein encoded by dna
10/13/1998	US5820862 T cell epitopes of the major allergens from dermatophagoides (house dust mite)
10/13/1998	US5820861 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
10/13/1998	US5820859 Administering a drug congugated to an antibody specific for the extracellular domain of gp180(erbb-3), which will not bind to erbb-2 or erbb; human mammary tumor line targeting
10/13/1998	US5820856 Treating bone marrow cells with gamma-irradiated modified cytotoxic t lymphoblastic leukemia cell line; bone marrow cells previously treated with cytokine(s)
10/13/1998	US5820845 Somatostatin-derived peptides for imaging and therapeutic uses
10/13/1998	US5820587 Method and kit for preventing erectile dysfunction
10/13/1998	US5820583 Surgical irrigation solution and method for inhibition of pain and inflammation
10/13/1998	CA1340082C Bovine interleukin-10c
10/10/1998	CA2233524A1 Novel compounds
10/09/1998	CA2234472A1 Vaccines
10/08/1998	WO1998044133A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract
10/08/1998	WO1998044130A1 RECOMBINANT MICROORGANISMS EXPRESSING ANTIGENIC PROTEINS OF $i(HELICOBACTER PYLORI)
10/08/1998	WO1998044129A1 Enhancement of immune response using targeting molecules
10/08/1998	WO1998044128A1 Novel human serine carboxypeptidase
10/08/1998	WO1998044124A1 Human mitochondrial adenylate kinase similar to gtp:amp phosphotransferase derivable from bovine or rat
10/08/1998	WO1998044121A1 Modified adenoviral fiber and target adenoviruses
10/08/1998	WO1998044119A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)
10/08/1998	WO1998044118A1 Chemokine beta-6
10/08/1998	WO1998044117A1 Human chemokine zsig-35
10/08/1998	WO1998044115A2 Regulators of g-protein signalling
10/08/1998	WO1998044114A1 Calcium-binding protein similar to reticulocalbin
10/08/1998	WO1998044113A1 Secreted proteins and polynucleotides encoding them
10/08/1998	WO1998044112A1 Human muscle derived growth factor - cardiac and pancreatic protein (capp) and gene
10/08/1998	WO1998044111A1 Thymus receptor tyrosine kinase (trtk) and methods of use
10/08/1998	WO1998044110A1 DNA ENCODING TRANSFORMING GROWTH FACTOR-β RECEPTOR ASSOCIATED PROTEIN
10/08/1998	WO1998044109A1 Cytostatin ii
10/08/1998	WO1998044107A1 Diagnosis and prognosis of glaucoma
10/08/1998	WO1998044106A1 Transcription factor islet-brain 1 (ib1)
10/08/1998	WO1998044105A1 Polypeptide expressed in the horny layer of epidermis and use thereof
10/08/1998	WO1998044104A2 Flip gene and flip protein
10/08/1998	WO1998044103A2 Protein for inhibiting apoptosis
10/08/1998	WO1998044102A2 Methods of modulating p33ing1 mediated apoptosis
10/08/1998	WO1998044101A1 Antisense oligonucleotides for mitogen-activated protein kinases as therapy for breast cancer
10/08/1998	WO1998044098A2 Strl33, a human fusion accessory factor associated with hiv infection
10/08/1998	WO1998044096A2 Mycobacterium recombinant vaccines
10/08/1998	WO1998044094A2 Helicobacter aliphatic amidase polypeptides, dna sequences encoding those polypeptides and uses thereof
10/08/1998	WO1998044088A2 Modulating the rad-nm23 interaction
10/08/1998	WO1998044021A1 Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same
10/08/1998	WO1998044001A1 High avidity polyvalent and polyspecific reagents
10/08/1998	WO1998044000A1 Recombinant protein c and protein s variants
10/08/1998	WO1998043999A1 Single-chain double-alpha peptide
10/08/1998	WO1998043997A1 Novel polypeptide having water channel activity and dna sequence
10/08/1998	WO1998043996A1 Active substance and composition inhibiting tumorous proliferation in ectoderm derived tissues
10/08/1998	WO1998043995A1 Novel anti-hiv complexes and medicinal compositions
10/08/1998	WO1998043993A2 Nucleic acid catalysts
10/08/1998	WO1998043680A1 Method for treating solid tumors comprising injecting macroaggregated albumin to increase retention time or radioactive/therapeutic agent in tumors
10/08/1998	WO1998043677A1 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
10/08/1998	WO1998043666A1 Antioxidant protein 2, gene and methods of use therefor
10/08/1998	WO1998043665A1 Preventive and/or therapeutic agent for kidney diseases
10/08/1998	WO1998043664A1 Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
10/08/1998	WO1998043663A1 Sandramycin analogs
10/08/1998	WO1998043662A1 Substances in order to achieve preference and create acceptance
10/08/1998	WO1998043661A1 Use of substances having oxytocin activity for preparation of medicaments for wound healing
10/08/1998	WO1998043660A1 Use of substances having oxytocin activity for preparation of medicaments for the treatment of affective pain syndromes
10/08/1998	WO1998043659A1 Selective lysis of malaria infected erythrocytes
10/08/1998	WO1998043658A1 Glucagon-like peptide-1 analogs
10/08/1998	WO1998043657A2 Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same
10/08/1998	WO1998043621A1 Nitrosylation to inactivate apoptotic enzymes
10/08/1998	WO1998043615A1 Method for oral delivery of proteins
10/08/1998	WO1998043611A1 Diffusional implantable delivery system
10/08/1998	WO1998043610A1 A method for producing jelly sweets which contain antibodies
10/08/1998	WO1998043601A1 Pharmaceutical composition, containing medium-chain fatty acids as active ingredients, for dental caries and periodontal disease
10/08/1998	WO1998043484A1 Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
10/08/1998	WO1998043483A1 Treatment for dutch elm disease

1 ... 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 2601 2602 2603 2604 ... 3163